fashion -WSS

fashion

author：comprehensive 2025-10-01 00:17:33 - browse：91174

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Heat waves linked to early deliveries, preterm births in new study

WSS

Childbirth

Heat waves linked to early deliveries, preterm births in new study

Biohaven protein

Health insurers say they are turning to AI to cut costs, improve care

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

leisure time

fashion

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Chimpanzees, like humans and whales, get menopause: Study

Trump demands the U.S. pay no more for drugs than other countries … again

Paying for Covid pills will soon shift to insurers

Drug repurposing or repositioning? The language matters

Insmed lung disease drug hits target in key Phase 3 trial

New air purifier tech could be key to improving indoor air quality

Eli Lilly to pay $200M for Beam’s stake in gene

State Dept. review finds Biden bears some blame for Afghanistan failures

Report: NIH

hotspot

Why Sanofi got shellacked over its spinoff

Insmed lung disease drug hits target in key Phase 3 trial

Diversifying clinical trials isn't enough to close racial gaps: study

Meta's Zuckerberg and Chan on track to put $50 billion into science

Insmed lung disease drug hits target in key Phase 3 trial

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

entertainment

explore

leisure time

leisure time